Evaluation of Relationship between Single-nucleotide Polymorphism in TNF-gene Promoter and Susceptibility to Atherosclerosis in Fatemeh Zahra Hospital

سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 109

فایل این مقاله در 13 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_REMJ-6-1_005

تاریخ نمایه سازی: 22 دی 1402

چکیده مقاله:

Background: Tumor necrosis factor-alpha (TNF-α) is a cytokine of proinflmmatory that elicits a polyvalent initial response of inflammatory cells in coronary atherosclerosis. Polymorphism and susceptibility to atherosclerosis may be related to the TNF-α gene promoter. The aim of this study was to investigate single nucleotide polymorphisms of the TNF-α gene promoter at two sites in patients with atherosclerosis referred to the Fatemeh al-Zahra Hospital, Sari City. Methods: This study was a case control study which involved ۱۲۰ patients (>۵۰% stenosis) and ۱۲۰ healthy individuals (<۱۰% stenosis). Genomic DNA was extracted with the phenol-chloroform method from white blood cells. Genotypes and TNF-α gene polymorphisms were analyzed using RFLP-PCR. Genotype frequency analysis, Hardy-Weinberg equilibrium test, and chi-square analysis have been conducted using SPSS software, version ۲۲. Results: Genotype frequencies of GA, GG, and AA at position –۳۰۸ of the TNF-α gene promoter in patients were ۱۲.۵%, ۷۵%, and ۱۲.۵%, respectively. The respective values in healthy subjects were ۷.۵%, ۲۱.۷%, and ۷۰.۸%. Allele A to G polymorphism increased the risk of disease by ۱۲.۷۱۶%. The genotype frequencies of the AC, CC, and AA at position –۸۶۳ of the TNF-α gene promoter in patients were ۳.۳%, ۶۹.۲%, and ۲۷.۵%, respectively. The respective values in healthy individuals were ۲.۵%, ۱۱.۷%, and ۸۵.۸%. Allele A to C polymorphism increased the risk of the disease by ۱۶.۳۷۳%. The difference in the risk of atherosclerosis was significant (P < ۰.۰۵). Conclusion: Mutations in TNF-α gene promoter could increase susceptibility to atherosclerosis. Determination of the genotypes of the individuals in these regions can help identify patients at risk for this disease.

نویسندگان

Somayyeh Nouri

Student of Toxicology of Department of Pharmacology; Toxicology, Faculty of Pharmacy, Pharmaceutical Sciences Branch, University Tehran –Iran(IAUPS)

Zahra Mousavi

Assistant Prof, Department of Pharmacology; Toxicology, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran –Iran (IAUPS)

Soheil Azizi

Associated prof. Department of Laboratory Medicine, Faculty of Allied Medical Sciences, Mazandaran University of Medical Sciences, Sari-Iran

Babak Bagheri

Associated prof.Cardiology research center,Fatemeh Zahra hospital,Mazandaran university of medical sciences, Sari Iran

Ramin Ataee

Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari-Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Reviewed by James Beckerman, MD, FACC on© ۲۰۱۴ WebMD, LLC. ...
  • R., R., Atherosclerosis–an inflammatory disease. N Engl J Med, ۱۹۹۹. ...
  • Libby P, R.P., Maseri A. , Inflammation and atherosclerosis. Circulation., ...
  • J., B., EMC-Cardiologie Ange´ iologie . Atherosclerosis., ۲۰۰۵. ۲: p. ...
  • Skoog T, D.W., Boquist S, Skoglund-Andersson C, Karpe F, Tang ...
  • Bemelmans MH, v.T.L., BuurmanWA. , Tumor necrosis factor: function, release ...
  • Bochner BS, L.F., Gimbrone Jr MA, Newman W, Sterbinsky SA, ...
  • A., M., The interplay between primary and secondary cytokines. Cytokinesinvolved ...
  • Feingold KR, G.C., Role of cytokines in inducing hyperlipidemia. . ...
  • Hotamisligil GS, S.N., Spiegelman BM. , Adipose expression of tumornecrosis ...
  • Ridker PM, R.N., Pfeffer M, Sacks F, Lepage S, Braunwald ...
  • Valgimigli M, C.C., Malagutti P, Merli E, Soukhomovskaia O, Francolini ...
  • Cesari M, P.B., Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell ...
  • Cesari M, P.B., Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell ...
  • Khot UN, K.M., Bajzer CT, Sapp SK, Ohman EM, Brener ...
  • Haddy N, S.C., Droesch S, Zaiou M, Siest G, Ponthieux ...
  • in the human tumor necrosis factor alpha promoter on transcriptional ...
  • Pai JK, P.T., Ma J, Manson JE, Hankinson SE, Joshipura ...
  • Vendrell J, F.-R.J., Gutierrez C, Zamora A, Simon I, Bardaji ...
  • Abraham LJ, K.K., Impact of the -۳۰۸ TNF promoter polymorphism ...
  • Kaluza W, R.E., Grossmann S, Hug R, Schopf RE, Galle ...
  • Chisari FV, F.C., Hepatitis B virus immunopathogenesis. Annu Rev Immunol., ...
  • Gao QJ, L.D., Zhang SY, Jia M, Wang LM, Wu ...
  • Bayley J, O.T., Verweij C. , Is there a future ...
  • Liping Hou , J.H., Xiangfeng Lu,Laiyuan Wang,Zhongjie Fan,Dongfeng Gu. , ...
  • Koch W, K.A., Bo¨ ttiger C, Mehilli J, von Beckerath ...
  • Yamada Y, I.S., Izawa H, Tanaka M, Yokota M. , ...
  • Herrmann SM, R.S., Nicaud V, Mallet C, Arveiler D, Evans ...
  • Allen RA, L.E., Roberts DH, Park BK, Pirmohamed M. , ...
  • Szalai C, F.G., Duba J, Kramer J, Romics L, Prohaszka ...
  • Furuta M, Y.Y., Ito K, Gabazza EC, Katsuki A, Tanaka ...
  • Ackerman H, U.S., Mott R, Richardson A, Sisay-Joof F, Katundu ...
  • Cho HC, Y.G., Lee MY, Kim HS, Shin DH, Kim ...
  • Day CP, G.J., Daly AK, StewartMW, Avery PJ,Walker M. , ...
  • Culpan D, M.S., Ford JM, Nicoll JA, Griffin WS, Dewar ...
  • نمایش کامل مراجع